Actuate Therapeutics Inc (ACTU) vs LeonaBio, Inc. (LONA)
A side-by-side comparison of Actuate Therapeutics Inc and LeonaBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACTU
Actuate Therapeutics Inc
$0.80HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
LONA
LeonaBio, Inc.
$5.58HealthcareDelayed quote: Oct 6, 2026, 11:09 AM EDT
Total return — ACTU vs LONA
growth of $100 · dividends reinvested · last 2yACTU -89.8% (-68.1%/yr)LONA -81.1% (-56.6%/yr)LONA compounded faster over this window
ACTU LONA
ACTU vs LONA: by the numbers
- •LONA is the larger company ($22M vs $19M market cap).
Metrics side by side
Valuation
| Metric | ACTU | LONA |
|---|---|---|
| P/B ratio | 19.44 | 0.66 |
Profitability
| Metric | ACTU | LONA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -2067.81% | -421.06% |
| ROIC | -1489.99% | -248.21% |
Growth (annualized)
| Metric | ACTU | LONA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -43.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.